As part of the campaign, SHL has collaborated with over 300 pulmonologists and chest physicians in more than 500 hospitals and clinics across four countries.
Additionally, a tutorial on how to use a DPI (Dry Powder Inhaler) machine will be made available through this QR code.
Aniruddha Rajurkar, CEO, SAVA Healthcare Limited, said, “Asthma is a chronic respiratory condition affecting millions of people worldwide.
Nepal is the second highest country which alone accounts for more than 100 deaths per 1,00,000 every year.
Recently, SAVA Healthcare forayed into the Nepal market with a range of the latest DPI products that offer rapid onset of action in conditions like asthma and chronic obstructive pulmonary disease (COPD).
As part of the campaign, SHL has collaborated with over 300 pulmonologists and chest physicians in more than 500 hospitals and clinics across four countries.
Read More
In line with the theme of the year titled, ‘Asthma Education Empowers’, a QR code has been placed at the hospitals and doctors’ clinics to provide easy access to basic preventive information about asthma. Additionally, a tutorial on how to use a DPI (Dry Powder Inhaler) machine will be made available through this QR code.
Aniruddha Rajurkar, CEO, SAVA Healthcare Limited, said, “Asthma is a chronic respiratory condition affecting millions of people worldwide. By partnering with medical professionals overseas and leveraging QR technology, we aim to extend the medical expertise of India to empower individuals in other countries with the knowledge and tools they need to effectively prevent and cure from asthma.”
According to the Global Initiative for Asthma (GINA), Asthma is one of the most common chronic non-communicable diseases that affects over 260 million people and is responsible for over 4,50,000 deaths each year worldwide, most of which are preventable. Nepal is the second highest country which alone accounts for more than 100 deaths per 1,00,000 every year.
Recently, SAVA Healthcare forayed into the Nepal market with a range of the latest DPI products that offer rapid onset of action in conditions like asthma and chronic obstructive pulmonary disease (COPD).
